Jennifer Buell - 29 Sep 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Chief Executive Officer, Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact for Jennifer S. Buell
Issuer symbol
INKT
Transactions as of
29 Sep 2023
Net transactions value
-$151,419
Form type
4
Filing time
03 Oct 2023, 21:15:05 UTC
Previous filing
29 Sep 2023
Next filing
13 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Tax liability $28,845 -25,000 -2.3% $1.15 1,051,465 29 Sep 2023 Direct F1
transaction INKT Common Stock Tax liability $61,155 -58,550 -5.6% $1.04 992,915 02 Oct 2023 Direct F2
transaction INKT Common Stock Tax liability $61,418 -65,000 -6.5% $0.9449 927,915 03 Oct 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.99 to $1.20. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.875 to $1.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.